These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 35303904)

  • 1. Cancer vaccines as promising immuno-therapeutics: platforms and current progress.
    Liu J; Fu M; Wang M; Wan D; Wei Y; Wei X
    J Hematol Oncol; 2022 Mar; 15(1):28. PubMed ID: 35303904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell-based vaccine: an effective strategy for eradication of cancer cells.
    Sadeghi Najafabadi SA; Bolhassani A; Aghasadeghi MR
    Immunotherapy; 2022 Jun; 14(8):639-654. PubMed ID: 35481358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Cancer Vaccine Research.
    Liu N; Xiao X; Zhang Z; Mao C; Wan M; Shen J
    ACS Biomater Sci Eng; 2023 Nov; 9(11):5999-6023. PubMed ID: 37921277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanovaccines: An effective therapeutic approach for cancer therapy.
    Gurunathan S; Thangaraj P; Wang L; Cao Q; Kim JH
    Biomed Pharmacother; 2024 Jan; 170():115992. PubMed ID: 38070247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic cancer vaccines: advancements, challenges, and prospects.
    Fan T; Zhang M; Yang J; Zhu Z; Cao W; Dong C
    Signal Transduct Target Ther; 2023 Dec; 8(1):450. PubMed ID: 38086815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Cancer Vaccine Efficiency by Nanomedicine.
    Cai J; Wang H; Wang D; Li Y
    Adv Biosyst; 2019 Mar; 3(3):e1800287. PubMed ID: 32627400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines.
    Viswanath DI; Liu HC; Huston DP; Chua CYX; Grattoni A
    Biomaterials; 2022 Jan; 280():121297. PubMed ID: 34902729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer vaccines and immunotherapies: emerging perspectives.
    Henderson RA; Mossman S; Nairn N; Cheever MA
    Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model.
    Peterson M; Murphy SN; Lainson J; Zhang J; Shen L; Diehnelt CW; Johnston SA
    BMC Immunol; 2020 May; 21(1):25. PubMed ID: 32370785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Vaccines for Cancer Immunotherapy.
    Wang J; Mamuti M; Wang H
    ACS Biomater Sci Eng; 2020 Nov; 6(11):6036-6052. PubMed ID: 33449675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoantigen: A New Breakthrough in Tumor Immunotherapy.
    Zhang Z; Lu M; Qin Y; Gao W; Tao L; Su W; Zhong J
    Front Immunol; 2021; 12():672356. PubMed ID: 33936118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospect and progress of personalized peptide vaccinations for advanced cancers.
    Sakamoto S; Noguchi M; Yamada A; Itoh K; Sasada T
    Expert Opin Biol Ther; 2016; 16(5):689-98. PubMed ID: 26938083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Antigen-Based Nanovaccines for Cancer Immunotherapy: A Review.
    Zhao J; Du G; Sun X
    J Biomed Nanotechnol; 2021 Nov; 17(11):2099-2113. PubMed ID: 34906272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite peptide-based vaccines for cancer immunotherapy (Review).
    Yang J; Zhang Q; Li K; Yin H; Zheng JN
    Int J Mol Med; 2015 Jan; 35(1):17-23. PubMed ID: 25395173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical and Synthetic Biology Approaches for Cancer Vaccine Development.
    Hossain F; Kandalai S; Zhou X; Zhang N; Zheng Q
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for developing and optimizing cancer vaccines.
    Maeng HM; Berzofsky JA
    F1000Res; 2019; 8():. PubMed ID: 31131086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunotherapy for pediatric solid tumors.
    Hegde M; Moll AJ; Byrd TT; Louis CU; Ahmed N
    Cytotherapy; 2015 Jan; 17(1):3-17. PubMed ID: 25082406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities.
    Shemesh CS; Hsu JC; Hosseini I; Shen BQ; Rotte A; Twomey P; Girish S; Wu B
    Mol Ther; 2021 Feb; 29(2):555-570. PubMed ID: 33038322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole cell vaccines--past progress and future strategies.
    Keenan BP; Jaffee EM
    Semin Oncol; 2012 Jun; 39(3):276-86. PubMed ID: 22595050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.